U.S. Online Retail and Ecommerce Stock News

NasdaqGS:KMB
NasdaqGS:KMBHousehold Products

Assessing Whether Kimberly-Clark (KMB) Looks Undervalued After Recent Mixed Share Price Performance

What recent performance says about Kimberly-Clark Kimberly-Clark (KMB) has drawn investor attention after a mixed run in its shares, with a small 1-day gain, a decline over the past week, and positive moves over the past month and past 3 months. That recent pattern, alongside a last close near US$104.91 and a value score of 4, is prompting closer scrutiny of how its personal care and tissue brands may relate to earnings power and long-term total returns. See our latest analysis for...
NYSE:CVS
NYSE:CVSHealthcare

Is CVS Health (CVS) Pricing Reflect The 25% One Year Rally And Policy Risks

If you are wondering whether CVS Health's current share price gives you a fair deal, you are not alone. This article will walk through what that price might imply about value. Over the past year, CVS Health has returned 25.2%, compared with a 2.4% move over the last 30 days and a 0.9% change in the past week, while year to date the stock shows a 1.8% decline from its last close of US$78.69. Recent headlines have focused on CVS Health's role in the broader US healthcare and pharmacy space,...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

Sotera Health Ownership Shift As 25m Share Sale Tests Valuation

Major shareholders Warburg Pincus LLC and GTCR LLC launched a secondary offering of 25,000,000 shares of Sotera Health (NasdaqGS:SHC). The offering consists solely of shares held by these existing investors, with Sotera Health not issuing new shares or receiving proceeds. The transaction focuses on ownership changes and liquidity for current holders rather than new capital for the company. Sotera Health, a provider of sterilization and lab testing services to the healthcare and life...
NYSE:SM
NYSE:SMOil and Gas

SM Energy’s New US$1b Notes Recast Debt Profile After Civitas Merger

SM Energy (NYSE:SM) has launched and priced US$1b in senior notes. The company plans to use the proceeds to fund a US$750m tender offer for its 2028 notes and to further optimize its debt profile. The transaction follows the recent merger with Civitas Resources and is part of post deal balance sheet repositioning. SM Energy is an independent oil and gas producer, and the Civitas merger has quickly shifted attention from deal terms to balance sheet structure. By issuing new senior notes and...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Should Corpay’s Earnings Beat And M&A Push Require Action From Corpay (CPAY) Investors?

In the past quarter, Corpay, Inc. reported stronger-than-expected fourth-quarter 2025 results, with earnings per share rising 12.7% year over year and highlighting momentum across its payment solutions. Recent acquisitions of Alpha Group International, GPS Capital Markets, and Paymerang have broadened Corpay’s product suite and customer reach, underscoring how M&A is reshaping its payments platform. We’ll now examine how Corpay’s better-than-expected earnings and recent acquisitions...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

A Look At Kiniksa Pharmaceuticals International’s Valuation After Strong 2025 Growth And ARCALYST Commercial Momentum

Kiniksa Pharmaceuticals International (KNSA) is back in focus after reporting fourth quarter and full year 2025 results, showing higher revenue and a shift to profitability that has drawn fresh attention from traders. See our latest analysis for Kiniksa Pharmaceuticals International. The earnings release on 24 February, followed by plans to present at the TD Cowen Health Care Conference and a recent ESOP related shelf filing, comes after a strong run, with a 90 day share price return of...
NYSE:SGI
NYSE:SGIConsumer Durables

Is Somnigroup International (SGI) Still Attractive After The Recent Share Price Pullback?

If you are wondering whether Somnigroup International is still worth the current price, this article will walk you through what that market tag might really mean for long term investors. The share price closed at US$82.52, with a 9.4% decline over the last 7 days and an 11.1% decline over the last 30 days, while the 1 year return sits at 41.9% and the 3 year and 5 year returns are 110.9% and 134.5% respectively. These moves sit against a backdrop of ongoing coverage around Somnigroup...
NasdaqGS:ORIC
NasdaqGS:ORICBiotechs

A Look At ORIC Pharmaceuticals (ORIC) Valuation After Earnings Update And New Shelf Registration

Why ORIC Pharmaceuticals Just Drew Fresh Attention ORIC Pharmaceuticals (ORIC) is back on investor radar after releasing fourth quarter and full year 2025 results, alongside a new shelf registration that could allow the company to raise up to roughly US$35.1 million in common stock. See our latest analysis for ORIC Pharmaceuticals. ORIC Pharmaceuticals shares have been on a strong run, with a 69.52% year to date share price return and a 76.43% total shareholder return over the past year. The...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is GLOBALFOUNDRIES (GFS) Still Fairly Priced After Recent Share Price Strength?

If you are wondering whether GLOBALFOUNDRIES’ share price around US$48.33 still reflects fair value, you are not alone. This article is here to unpack that question in a clear way. The stock has returned 3.0% over the last 7 days, 18.8% over the past 30 days, 31.1% year to date, and 25.9% over the last year, while its 3 year return stands at a 27.2% decline. These moves have played out against a backdrop of ongoing interest in semiconductor manufacturing capacity and supply chains, with...
NYSEAM:BATL
NYSEAM:BATLOil and Gas

A Look At Battalion Oil (BATL) Valuation After Geopolitical Tensions And $15 Million Private Placement

Heightened tensions around Iran and the Strait of Hormuz have pushed Battalion Oil (BATL) into the spotlight, as investors gravitate toward U.S. onshore producers and react to the company’s recent $15 million private placement. See our latest analysis for Battalion Oil. The latest moves come on top of a very large recent rally, with the 7 day share price return above 3x and the year to date share price return also extremely strong, while the 1 year total shareholder return has more than...
NYSE:LXU
NYSE:LXUChemicals

LSB Industries (LXU) Is Up 21.0% After Return To Profitability And 2026 Guidance Release – Has The Bull Case Changed?

LSB Industries, Inc. reported past fourth-quarter and full-year 2025 results showing sales of US$165.05 million and US$615.21 million respectively, alongside a shift from net losses to net income and positive earnings per share from continuing operations. The company also issued detailed 2026 production and sales guidance for key nitrogen products and completed a US$26.22 million share repurchase program, signaling management’s confidence in its operating outlook and capital allocation...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Assessing Regeneron Pharmaceuticals (REGN) Valuation As Shares Trade Below Estimated Fair Value

Regeneron Pharmaceuticals overview Regeneron Pharmaceuticals (REGN) has drawn investor attention after its shares closed at US$764.93, with recent returns mixed across different time frames and a long term track record that some investors continue to monitor closely. See our latest analysis for Regeneron Pharmaceuticals. Recent trading has been a bit choppy, with a 1 day share price return showing a 2.87% decline and a 90 day share price return of 6.48%, while the 1 year total shareholder...
NYSE:DT
NYSE:DTSoftware

Assessing Dynatrace (DT) Valuation After Insider Share Purchase And AI Observability Focus

Dynatrace (DT) is back in focus after Executive Vice President Stephen McMahon bought 3,000 company shares, a move that coincides with growing attention on its artificial intelligence driven observability platform. See our latest analysis for Dynatrace. The insider purchase comes as Dynatrace’s share price has climbed to US$39.21, with a 1 month share price return of 13.42% and a 7 day gain of 7.87%, although the 1 year total shareholder return of 26.82% decline and 5 year total shareholder...
NYSE:EPAM
NYSE:EPAMIT

What EPAM Systems (EPAM)'s AI Surge and Cautious 2026 Outlook Means For Shareholders

In February 2026, EPAM Systems reported strong Q4 2025 results with double-digit revenue growth and rapidly expanding AI-native services, even as management issued cautious 2026 sales guidance and disclosed a revenue drop from the largest customer of its NEORIS business. This combination of robust operational performance, rising AI-related revenues and awards from partners like Microsoft and AWS, alongside conservative outlook and a new shareholder legal investigation, has sharpened debate...
NYSE:TNC
NYSE:TNCMachinery

Is ERP Turmoil And Legal Scrutiny Altering The Investment Case For Tennant (TNC)?

In February 2026, Tennant Company reported weaker fourth-quarter and full-year 2025 results, issued 2026 guidance, completed a share repurchase program of 1,288,096 shares for US$98.78 million, and signaled continued interest in acquisitions while facing multiple securities law investigations linked to disruptions from its new ERP system. Management’s comments highlight a tension between pursuing growth through acquisitions and returning cash via buybacks and dividends, at a time when...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum’s Brelovitug Phase 3 Milestones Reframe Rare Disease Growth Story

Mirum Pharmaceuticals has completed enrollment in its pivotal Phase 3 AZURE-1 trial of brelovitug in chronic hepatitis delta virus. The company has also completed screening in its AZURE-4 Phase 3 trial, another key study for brelovitug. Brelovitug holds FDA Breakthrough Therapy designation for chronic HDV infection, and these trials are expected to support an upcoming BLA submission. For investors watching NasdaqGM:MIRM, these trial milestones arrive with the stock trading around $87.84 and...
NYSE:NVGS
NYSE:NVGSOil and Gas

Navigator Holdings Loan Fuels Ethylene Fleet Growth And Debt Questions

Navigator Holdings (NYSE:NVGS) has secured a major loan to fund the construction of two new liquefied ethylene gas carriers. The financing supports expansion of its liquefied gas fleet focused on transporting ethylene for petrochemical customers. The new vessels are intended to add capacity and service flexibility in the liquefied gas transportation sector. Navigator Holdings, listed on the NYSE under the ticker NVGS, operates in liquefied gas shipping. The company serves petrochemical...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Cooper Companies Starts 2026 Strong As Premium Lenses Lift Outlook

Cooper Companies started fiscal 2026 with strong momentum, supported by the global rollout of its premium MyDay and MiSight contact lenses. Management reported margin expansion and benefits from recent reorganizations in the first quarter. The company raised full year earnings and free cash flow guidance following the successful expansion of its lens portfolio. Cooper Companies, traded as NasdaqGS:COO, is coming off a first quarter where operations and execution were in focus rather than...
NYSE:LAD
NYSE:LADSpecialty Retail

Lithia Motors Expands Nashville Presence With Toyota Of Gallatin Acquisition

Lithia Motors (NYSE:LAD) acquires Toyota of Gallatin, a dealership serving the Metro Nashville area. The deal expands Lithia’s presence in the Nashville market and adds to its broader dealership network. Lithia Motors, a large U.S. auto retailer, continues to build out its footprint with the addition of Toyota of Gallatin in the greater Nashville area. For you as an investor, this fits within a broader pattern of dealership expansion as auto retail groups seek access to regions with rising...
NYSE:IIPR
NYSE:IIPRIndustrial REITs

Is It Time To Reconsider Innovative Industrial Properties (IIPR) After Recent Cannabis Sector Rethink?

If you are wondering whether Innovative Industrial Properties is offering good value at around US$55.06 per share, you are not alone. This article is built to help you frame that question clearly. The stock has returned 0.8% over the last 7 days and 13.7% over the past month, while year to date it is up 11.3%. The 1 year return stands at a 13.1% decline, with a 54.8% decline over 5 years and a 10.1% decline over 3 years. Recent news flow around the cannabis real estate space has focused on...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet Investor Briefing To Clarify Cybersecurity Risks And Growth Priorities

Fortinet is planning an investor briefing during its Accelerate 2026 conference to outline its direction and business priorities. The session is expected to cover management's response to recent cybersecurity issues, including an AI assisted breach involving Fortinet firewalls. The event comes as analyst sentiment has been mixed and investors watch developments in margins and short interest. For investors tracking NasdaqGS:FTNT, the briefing lands at a time when the stock trades at $84.42,...
NasdaqGS:KHC
NasdaqGS:KHCFood

Kraft Heinz (KHC) Valuation After Mixed Q4 2025 Results And Halted Corporate Split

Why Kraft Heinz (KHC) is back in focus Kraft Heinz (KHC) has returned to investor watchlists after mixed Q4 2025 results, a cautious 2026 outlook for organic sales and margins, and a decision to pause its planned corporate separation. Instead of splitting the business, the company plans to commit US$600 million to new product development and selected price cuts. This pivot comes as analysts note ongoing pressure on sales trends and profitability. See our latest analysis for Kraft Heinz. At a...
NYSE:GRND
NYSE:GRNDInteractive Media and Services

Grindr Extends US$900m Buyback As Profitability Shifts Capital Priorities

Grindr (NYSE:GRND) expanded its share repurchase authorization by $400 million, bringing the total to $900 million. The company extended the duration of its buyback program through 2029. The plan allows Grindr to continue repurchasing stock over several years, subject to market conditions and corporate priorities. Grindr, known for its LGBTQ+ social and dating app, operates at the intersection of consumer tech and digital advertising, where user attention and engagement are core assets. For...
NasdaqGS:DAWN
NasdaqGS:DAWNBiotechs

Assessing Day One Biopharmaceuticals (DAWN) Valuation After OJEMDA’s Positive EMA Opinion And Licensing Progress

Regulatory progress and stock reaction Day One Biopharmaceuticals (DAWN) moved following a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use supporting conditional marketing authorization of OJEMDA for certain pediatric low grade glioma patients. This regulatory step, together with the company’s ex U.S. licensing agreement with Ipsen and updated 2026 pipeline milestones, has drawn investor attention to how OJEMDA and earlier stage programs...